 |
|
|
|
 For more information please contact:
Paul Henning
212.554.5462
paul@cameronassoc.com |
QuickLinks:
Press Releases »
Client Website »
Stock Quote »
Client Calendar » |
|
Biophan, Inc. (OTC BB: BIPH)
Biophan is dedicated to providing technologies that offer innovative and competitive advantages to the medical device industry. The Company is helping to commercialize the Myotech Circulatory Support System, which has significant potential to improve the treatment of acute heart failure. Biophan Technologies, Inc. holds a 68% interest in Myotech with rights to acquire additional equity, and is leading Myotech's business development efforts. Biophan is traded on the OTC market under the symbol BIPH, and is also listed on the Frankfurt Stock Exchange under the symbol BTN. For more information on Biophan, please visit our website at www.biophan.com.
|
|
April 23, 2008:
Biophan Approves Next Stage of Myotech Development
- download word.doc (40 Kb) »
|
April 16, 2008:
Biophan Expands Intellectual Property Portfolio With Two New Patents
- download word.doc (40 Kb) »
|
April 8, 2008:
Biophan Announces Memorandum of Understanding Between Myotech and PPA Technologies
- download word.doc (40 Kb) »
|
March 14, 2008:
Biophan Announces Appointment of John H. Bowers as Senior Technologist for Myotech
- download word.doc (40 Kb) »
|
February 27, 2008:
Biophan Announces Appointment of Jeanne Lesniak as Advisor for Regulatory and Clinical Affairs for Myotech
- download word.doc (40 Kb) »
|
February 25, 2008:
Biophan to Present at the Sachs Associates 7th Annual North America Forum for Investing & Partnering in Biotech
- download word.doc (40 Kb) »
|
February 7, 2008:
Biophan Names Harold Gubnitsky to Board of Directors
- download word.doc (40 Kb) »
|
February 6, 2008:
Biophan Names Travis E. Baugh to Board of Directors
- download word.doc (40 Kb) »
|
February 5, 2008:
CEO John Lanzafame Named to Biophan Board of Directors
- download word.doc (40 Kb) »
|
